
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9389386
[patent_doc_number] => 08685984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Methods for treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/935987
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 59184
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935987 | Methods for treating HCV | Jul 4, 2013 | Issued |
Array
(
[id] => 9375842
[patent_doc_number] => 08680106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Methods for treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/935983
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 63003
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935983
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935983 | Methods for treating HCV | Jul 4, 2013 | Issued |
Array
(
[id] => 12037630
[patent_doc_number] => 09815849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Compositions and methods for treating leukemia'
[patent_app_type] => utility
[patent_app_number] => 13/934843
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 108
[patent_no_of_words] => 32861
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13934843
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/934843 | Compositions and methods for treating leukemia | Jul 2, 2013 | Issued |
Array
(
[id] => 9811975
[patent_doc_number] => 20150023913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/933495
[patent_app_country] => US
[patent_app_date] => 2013-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 205149
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/933495 | Hepatitis C Virus Inhibitors | Jul 1, 2013 | Abandoned |
Array
(
[id] => 9295314
[patent_doc_number] => 20140038948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/926959
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48255
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/926959 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | Jun 24, 2013 | Abandoned |
Array
(
[id] => 9108338
[patent_doc_number] => 20130281470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/921233
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8071
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921233 | Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases | Jun 18, 2013 | Abandoned |
Array
(
[id] => 10279913
[patent_doc_number] => 20150164910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'ANTIVIRAL COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/407665
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18965
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407665
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407665 | ANTIVIRAL COMPOUNDS AND METHODS OF USE | Jun 13, 2013 | Abandoned |
Array
(
[id] => 9206003
[patent_doc_number] => 20140005180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/913369
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31245
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913369
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913369 | Phenyl amino pyrimidine compounds and uses thereof | Jun 6, 2013 | Issued |
Array
(
[id] => 10511054
[patent_doc_number] => 09238628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-19
[patent_title] => 'Phenyl amino pyrimidine compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/913362
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 31358
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913362 | Phenyl amino pyrimidine compounds and uses thereof | Jun 6, 2013 | Issued |
Array
(
[id] => 9198841
[patent_doc_number] => 20130338155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHOD FOR TREATING INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/909815
[patent_app_country] => US
[patent_app_date] => 2013-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 90839
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/909815 | METHOD FOR TREATING INFECTIONS | Jun 3, 2013 | Abandoned |
Array
(
[id] => 10176216
[patent_doc_number] => 09206412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Thioxothiazolidine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/907485
[patent_app_country] => US
[patent_app_date] => 2013-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 7
[patent_no_of_words] => 19404
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/907485 | Thioxothiazolidine inhibitors | May 30, 2013 | Issued |
Array
(
[id] => 11697590
[patent_doc_number] => 09687488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Compositions and methods for increasing neurotrophic peptides'
[patent_app_type] => utility
[patent_app_number] => 14/398704
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4750
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398704
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398704 | Compositions and methods for increasing neurotrophic peptides | May 2, 2013 | Issued |
Array
(
[id] => 9108302
[patent_doc_number] => 20130281434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/867016
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65300
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13867016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/867016 | Therapeutic compounds | Apr 18, 2013 | Issued |
Array
(
[id] => 9034893
[patent_doc_number] => 20130237531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/866353
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48270
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13866353
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/866353 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | Apr 18, 2013 | Abandoned |
Array
(
[id] => 9069361
[patent_doc_number] => 20130261117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/866469
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 204058
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13866469
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/866469 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | Apr 18, 2013 | Abandoned |
Array
(
[id] => 9932213
[patent_doc_number] => 20150080404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'NOVEL COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/394470
[patent_app_country] => US
[patent_app_date] => 2013-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8501
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394470
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394470 | NOVEL COMPOSITIONS AND METHODS | Apr 13, 2013 | Abandoned |
Array
(
[id] => 11053377
[patent_doc_number] => 20160250339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'Pegylated Artesunate Derivative, Pharmaceutical Composition and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/899138
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5464
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899138
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899138 | Pegylated artesunate derivative, pharmaceutical composition and use thereof | Apr 11, 2013 | Issued |
Array
(
[id] => 9198798
[patent_doc_number] => 20130338113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'MATERIALS AND METHODS FOR TREATING VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/856911
[patent_app_country] => US
[patent_app_date] => 2013-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8585
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13856911
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/856911 | Materials and methods for treating viral infections | Apr 3, 2013 | Issued |
Array
(
[id] => 9004505
[patent_doc_number] => 20130225630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/852773
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2266
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852773 | TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS | Mar 27, 2013 | Abandoned |
Array
(
[id] => 9004506
[patent_doc_number] => 20130225631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/852779
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2266
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852779
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852779 | TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS | Mar 27, 2013 | Abandoned |